Pure Global

Comparison Of Outcome Of Antibiotic Coated Vicryl Vs Non-Coated Vicryl In Abdominal Fascial Closure After Laparotomy In Children - Trial NCT06129773

Access comprehensive clinical trial information for NCT06129773 through Pure Global AI's free database. This phase not specified trial is sponsored by Muhammad Adeel Ashiq and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06129773
Not yet recruiting
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT06129773
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Comparison Of Outcome Of Antibiotic Coated Vicryl Vs Non-Coated Vicryl In Abdominal Fascial Closure After Laparotomy In Children

Study Focus

Surgical Site Infection

antibiotic coated vicryl used for fascial closure

Interventional

procedure

Sponsor & Location

Muhammad Adeel Ashiq

Children Hospital and Institute of Child Health, Lahore

Timeline & Enrollment

N/A

Nov 01, 2023

Dec 01, 2024

100 participants

Primary Outcome

Rate of surgical site infection

Summary

We are investigating outcome of antibiotic coated vicryl versus non coated vicryl in terms of
 rate of surgical site infection and lebgth of hospital stay in children after lalaprotomy for
 perforated viscera. total 100 patients will be taken and 50 in each group.

ICD-10 Classifications

Infection following a procedure, not elsewhere classified
Bacterial infection of unspecified site
Other bacterial infections of unspecified site
Infection of obstetric surgical wound
Other specified local infections of skin and subcutaneous tissue

Data Source

ClinicalTrials.gov

NCT06129773

Non-Device Trial